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ABSTRACT
The leaves of Bambusa vulgaris possesses several bioactivities and is used in traditional medicinal systems. However, its 
anti-diabetic activity has not been scientifically investigated so far. The present study was carried out to evaluate the anti-
diabetic activity  of  petroleum  ether  extract  of  Bambusa  vulgaris (family:  Poaceae)  leaves  in  Streptozotocin induced 
diabetic rats. The preliminary phytochemical study showed the presence of phytosterols and tannins. From the toxicity 
study it was observed that petroleum ether extract of Bambusa vulgaris (PEBV) was nontoxic up to the dose of 2000 
mg/kg body weight. In this study, animals received continuous oral administration of PEBV for a period of 15 days at the 
doses of 200 mg/kg and 400 mg/kg body weight. The control group was administered distilled water for the same duration. 
The blood glucose level was determined by GOD-POD kit method.  The effect of PEBV was compared with oral dose of 
0.5mg/kg  Glibenclamide.  The  results  showed  that  the  PEBV  significantly  lowered  the  fasting  blood  sugar  level  of 
hyperglycemic rats in a dose dependent manner and it was also comparable to that of the standard drug Glibenclamide.
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INTRODUCTION
Diabetes  mellitus  is  a  major  and  growing  public  health 
problem  throughout  the  world.  According  to  WHO 
projections, the prevalence of diabetes is likely to increase by 
35%. Currently there are over 150 million diabetic patients 
worldwide.  Recent  estimates  project  that  the  number  of 
patients  diagnosed  with  Type  II  diabetes  will  more  than 
double to 300 million before 2025. India has more than 30 
million people with diabetics. It is estimated that by 2025, the 
number  of  diabetics  will  rise  to  57  million  in  India,  the 
highest number of diabetics in the world.
[1-2]
There are several drugs in clinical practice for the treatment 
of diabetes mellitus. Many of these oral anti-diabetic agents 
have  been  reported  to  show serious  adverse  effects.  It  is 
apparent  that  due to  the  side  effects  of the  currently  used 
drugs, there is a need for a potent drug with minimal adverse 
effects,  which  can  be  taken  for  long  durations.  Plant 
materials which are being used as traditional medicine for the 
treatment of diabetes are considered one of the good sources 
for a new drug or a lead to make a new drug. Throughout the 
world  many  traditional  plant  treatments  for  diabetes  exist. 
However,  few have  received  scientific  or medical  scrutiny 
and  the  WHO  has  recommended  that  traditional  plant 
treatments for diabetes warrant further evaluation.
[3-5]
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Bambusa vulgaris, commonly known as golden bamboo is 
taxonomically  a  grass,  but  its  habit  is  tree-like.  It  occurs 
throughout India in areas up to 2100 m elevation. Bamboo 
leaves  have  been  claimed  to be  used  as  astringent, 
ophthalmic  solution,  sudorific  and  febrifuge.  In  Nigerian 
folklore  medicine,  bamboo  is  claimed  to  be  used  as  an 
emmenagogue,  abortifacient,  appetizer  and  for  managing 
respiratory diseases as well as gonorrhea. Leaves are used in 
ayurvedic  medicine  in  ptosis  and  paralytic  complaints.The 
leaves have been used in Indian folk medicine to treat various 
inflammatory  conditions.
[6-8] Though  the  plant  and  its 
extracts have been used in the folklore medicine extensively, 
there is no scientific evidence for such activities available in 
established scientific journals of repute. Keeping this in view, 
the present study has been undertaken to investigate the anti-
diabetic potential of petroleum ether extract of B. vulgaris in 
Streptozotocin induced diabetic rats.
MATERIALS AND METHODS
Chemicals 
Streptozotocin (STZ) (purchased from Sigma, St Loius, MO, 
USA) and glucose oxidase/peroxidase (GOD/POD) reagent 
(glucose kits were obtained from Randox Laboratories Ltd, 
UK). All other chemicals used were of analytical grade.
Plant material
The  leaves  of  Bambusa vulgaris was  collected  from  ABS 
Botanical & Research Institute, Karipatty, Tamil Nadu, India. 
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by  the  Botanical  Survey  of  India,  Southern  circle,  TNAU 
Campus, Coimbatore.
Preparation of plant extract
The  collected  leaves  of Bambusa vulgaris were  dried  in 
shade  at  room  temperature  and  reduced  to  coarse  powder 
using a mechanical grinder. The dried powder material was 
extracted with petroleum ether (60-80°C) by hot continuous 
extraction in a Soxhlet’s apparatus for 48 h. The extract was 
concentrated under reduced pressure and stored in an air tight 
container.
Phytochemical screening
The petroleum ether extract was screened for the presence of 
various  phytoconstituents  like  steroids,  alkaloids,  tannins, 
flavonoids,  and  glycosides  by  employing  standard 
phytochemical tests.
[9]
Animals
Swiss albino mice of female sex weighing 20-25 g and male 
albino rats of Wistar strain weighing around 160-180 g were 
procured  from  Agricultural  University,  Manuthy,  Trissure. 
They were acclimatized to animal house condition, fed with 
commercial  pellet  raw  chow  (Hindustan  Lever  Ltd, 
Bangalore) and have free access to water. The experimental 
protocol  was  approved  by  the  IAEC  (Institutional  Animal 
Ethical Committee).
Toxicity study
Acute  oral  toxicity  study  was  performed  in  mice  by 
following  Organization  for  Economic  Co-operation  and 
Development (OECD) guidelines AOT No. 425.
[10]
Induction of diabetes
Streptozotocin  (STZ)  induced  hyperglycaemia  has  been 
described as a useful experimental model to study the activity 
of hypoglycaemic agents. After overnight fasting (deprived 
of food for 16 hours, had been allowed free access to water), 
diabetes was induced in rats by intraperitoneal injection of 
STZ dissolved in 0.1  M sodium citrate buffer pH 4.5 at a 
dose of 50 mg/kg body weight. After the injection they have 
free access to food and water. The animals were allowed to 
drink  5  %  glucose  solution  overnight  to  overcome  the 
hypoglycaemic  shock.  The  development  of  diabetes  was 
confirmed  after  48  h  of  the  Streptozotocin  injection.  The 
animals having fasting blood glucose levels more than 200 
mg/dL  were  considered  as  diabetic  rats  and  used  for 
experimentation.
Experimental protocol
In  the  diabetic  rat,  5  days  after  the  induction  of  diabetes, 
animals  were divided into  four groups each having  6 rats. 
Non  diabetic  animals  are  grouped  for  control.  Total  of  5 
groups of animals of six each were used for study.
Group I: Received 2% w/v gum acacia 1ml/kg orally served 
as control group (non diabetic control).
Group II: Served as STZ induced diabetic control received 
2% w/v gum acacia 1ml/kg orally for 15 days. 
Group III: Streptozotocin induced diabetic animals received 
petroleum ether extract of Bambusa vulgaris leaf 200 mg/kg 
body weight once daily orally for 15 days.
Group IV: Streptozotocin induced diabetic animals received 
petroleum ether extract of Bambusa vulgaris leaf 400 mg/kg 
body weight once daily orally for 15 days.
Group V: Streptozotocin induced diabetic animals received 
the  standard  drug  Glibenclamide 0.5  mg/kg  body  weight 
once daily orally for 15 days.
All the group of animals received the treatment for 15 days. 
Rats  were  fasted  overnight  and  the  blood  was  withdrawn 
from the retro-orbital plexus on the 5
th day of induction of 
diabetes and 15
th and 20
th day post induction (that is 10 and 
15 days of drug treatment) to determine the blood glucose 
level by glucose oxidase - peroxidase (GOD/POD) method. 
The  change  in  body  weight  was  observed  throughout  the 
treatment period in experimental animals.
Statistical analysis
All  the  grouped  data  were  expressed  as  mean  ±  SD. 
Difference  between  the  control  and  treatment  groups  were 
tested for significance using ANOVA followed by Dunnett’s 
test. P<0.05 were considered significant.
RESULTS
Phytochemical screening
The preliminary phytochemical studies showed the presence 
of  phytosterols  and  tannins  in petroleum  ether  extract  of 
Bambusa vulgaris leaves.
Acute toxicity studies
In acute  oral toxicity study,  the petroleum ether extract  of 
Bambusa vulgaris leaves did not produced lethality up to the 
dose level of 2000 mg/kg.
Anti-diabetic activity
Fasting blood glucose level (FBS) was measured on 5
th, 15
th
and 20
th day of post induction. The FBS level of Group III 
(PEBV 200 mg/kg) and Group IV (PEBV 400 mg/kg) on 15
th 
day of post induction (10 days of treatment) were 196.11 ± 
1.3 mg/dL and 162.16 ± 0.45 mg/dL respectively.  The FBS 
level  of  Glibenclamide (0.5  mg/kg)  treated  animal  was 
112.11 ± 0.92 mg/dL on 15
th day of post induction. The FBS 
level of Group III (PEBV 200 mg/kg) and Group IV (PEBV 
400  mg/kg)  on  20
th  day  of  post  induction  (15  days  of 
treatment)  were  175.41  ±  0.94  mg/dL  and  144.75  ±  0.31 
mg/dL respectively.  The FBS level of Glibenclamide (0.5 
mg/kg) treated animal was 107.21 ± 0.75 mg/dL on 20
th day 
of post induction.
The FBS levels in STZ treated rats were significantly high (P 
< 0.001)  when compared  to the non diabetic  control.  Oral 
administration  of  PEBV  at  the  dose  of  200  mg/kg  body 
weight showed a significant decrease in FBS level (248.02 ± 
1.9 to 175.41 ± 0.94 mg/dL, P < 0.01), as compared with the 
diabetic control group. Oral administration of PEBV at the 
dose  of  400  mg/kg  body  weight  showed  a  significant 
decrease in FBS level (250.14 ± 1.6 to 144.75 ± 0.31 mg/dL, 
P  <  0.001),  as  compared  with  the  diabetic  control  group. 
Glibenclamide treated group showed a significant decrease in 
the  FBS  levels  (249.09  ±  2.1  to  107.21  ±  0.75  mg/dL, 
P<0.001),  as  compared  to  the  diabetic  control.  The 
continuous oral administration of PEBV for a period of 15 
days at the doses of 200 mg/kg and 400 mg/kg body weight 
showed a significant decrease in fasting blood sugar (FBS) 
level, which was dose dependant and also comparable to that 
of the standard drug Glibenclamide.
DISCUSSION
Any drug that is effective in diabetes will have the ability to 
control the rise in glucose level by different mechanisms and 
the ability of the extracts to prevent hyperglycaemia could be 
determined  by  hyperglycaemic  animal  model. In  animals, 
diabetes can be induced by partial pancreatectomy or by the 
administration  diabetogenic  drugs  such  as  streptozotocin,
alloxan, ditizona and anti-insulin serum. Streptozotocin is a 
naturally  occurring  nitrosourea  product  of  Streptomyces 
achromogenes, and it is widely used to induce  diabetes in Senthilkumar et al. / Evaluation of Anti-diabetic Activity of Bambusa vulgaris leaves ……
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experimental  animals.  Usually,  the intraperitoneal injection 
of a single dose (50 mg/kg body weight) of it exerts direct 
toxicity on β cells resulting in necrosis within 48-72 h and 
causes a permanent hyperglycemia. Streptozotocin was used 
in the present study for the induction of diabetes in rats.
Table 1: Effect of petroleum ether extract of Bambusa vulgaris on 
fasting blood sugar (mg/dL) level in STZ induced diabetic rats.
Groups
Post Induction Days
5
th 15
th 20
th
Group I
Non diabetic control 67.65 ± 0.96 68.12 ± 0.94 69.82 ± 1.1
Group II
Diabetic control
252.04 ± 
2.1***
239.11 ± 
1.6***
238.23 ± 
1.2***
Group III
Diabetic control + 
MEBV (200 mg/kg)
248.02 ± 1.9 196.11 ± 
1.3**
175.41 ± 
0.94**
Group IV
Diabetic control + 
MEBV(400 mg/kg)
250.14 ± 1.6 162.16 ± 
0.45***
144.75 ± 
0.31***
Group V
Diabetic control + 
Glibenclamide 
(0.5mg/kg)
249.09 ± 2.1 112.11 ± 
0.92***
107.21 ± 
0.75***
All the values are expressed as mean   ± SEM, n=6 in each group. Values are 
significantly different from control. 
*P < 0.05;
**P < 0.01;
***P < 0.001
Fig. 1: Effect of petroleum ether extract of Bambusa vulgaris on fasting 
blood sugar (mg/dL) level in STZ induced diabetic rats
Our observations are in well agreement with the reports by 
several  workers  that  STZ  induced  diabetes  mellitus  and 
insulin deficiency leads to increased blood glucose.
[11] The 
blood  glucose  data  obtained  clearly  indicate  that  the 
petroleum  ether  extract  of  Bambusa vulgaris  produce 
significant anti diabetic effects in STZ induced diabetic rats.
The  mechanism  of  anti-diabetic activity  of  the  extracts  of 
Bambusa vulgaris cannot be proposed by the present study. 
The  possibility  exists  that  the  plant  may  act  by  either  a 
pancreatic or extra-hepatic mechanism or both mechanisms. 
A  pancreatic  mode  of  action  is  feasible  because  in  mild 
diabetes not all the beta cells of the pancreas are destroyed by 
STZ. Surviving  beta cells retain the capacity to synthesize 
and secrete insulin.
[12-13]
In  conclusion,  the  petroleum  ether  extract  of  Bambusa 
vulgaris leaves showed a significant anti-diabetic activity in 
streptozotocin induced diabetic rats. The phytosterols present 
in petroleum ether extract may be possibly responsible for 
the anti-diabetic activity. However, we suggest that further 
work should be carried out at cellular and molecular levels to 
find  out  the  absolute  mechanism  of  action  of  the  plant in 
experimental  diabetes.  The  present  investigation  has  also 
opened avenues for further research to the development of 
potent  phytomedicine  for  diabetes  mellitus  from  the
Bambusa vulgaris.
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